
    
      Patients with localized basocellular carcinoma of the skin, will receive oral Itraconazole,
      200 mg once daily, for 60 days, before surgery with curative intent.

      Tumor area regression will be measured through dermatologic evaluation and photographic
      documentation on baseline and at the end of the 60 day treatment period.

      The activity of the Hedgehog pathway will be measured on tissue samples obtained at the time
      of diagnosis and at the time of curative intent surgery, through the measuring of the Ki67
      index.
    
  